Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Cullinan Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- +3 vs. Q2 2024
- Shares held
- 65.0M
- +5.63M (+9.5%) vs. Q2 2024
- Total value
- $1.09B
- +$51.6M (+5.0%) vs. Q2 2024
- New holders
- 20
- 66 more added
- Sold out
- 17
- 28 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 410,830 | $6.88M | 2.44% | +33,507+8.9% | Added |
| Ameriprise Financial Inc | 417,508 | $6.99M | 0.00% | +13,630+3.4% | Added |
| Charles Schwab Investment Management Inc | 423,959 | $7.10M | 0.00% | +53,328+14.4% | Added |
| Avidity Partners Management LP | 425,000 | $7.11M | 0.36% | −1,134,826−72.8% | Reduced |
| Northern Trust Corp | 470,885 | $7.88M | 0.00% | +174,033+58.6% | Added |
| Deutsche Bank AG | 560,873 | $9.39M | 0.00% | +5,806+1.0% | Added |
| Twin Focus Capital Partners, LLC | 595,489 | $9.97M | 1.57% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 657,905 | $11.0M | 7.65% | 00.0% | Unchanged |
| Morgan Stanley | 673,372 | $11.3M | 0.00% | −164,911−19.7% | Reduced |
| Goldman Sachs Group Inc | 700,552 | $11.7M | 0.00% | +247,765+54.7% | Added |
| Rock Springs Capital Management LP | 736,914 | $12.3M | 0.40% | +78,576+11.9% | Added |
| Millennium Management LLC | 788,567 | $13.2M | 0.01% | +788,567 | New |
| Patient Square Capital LP | 824,705 | $13.8M | 5.12% | +824,705 | New |
| Boxer Capital, LLC | 907,895 | $15.2M | 0.75% | +250,000+38.0% | Added |
| Tang Capital Management LLC | 921,138 | $15.4M | 1.10% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 1,022,905 | $17.1M | 0.00% | +263,145+34.6% | Added |
| Marshall Wace, LLP | 1,053,764 | $17.6M | 0.02% | −130,273−11.0% | Reduced |
| OrbiMed Advisors LLC | 1,070,055 | $17.9M | 0.33% | −77,600−6.8% | Reduced |
| Nextech Invest AG | 1,141,145 | $19.1M | 2.68% | −80,000−6.6% | Reduced |
| Braidwell LP | 1,176,173 | $19.7M | 0.56% | +1,000,000+567.6% | Added |
| Geode Capital Management, LLC | 1,208,421 | $20.2M | 0.00% | +231,935+23.8% | Added |
| Siren, L.L.C. | 1,211,357 | $20.3M | 1.01% | +1,211,357 | New |
| Adage Capital Partners GP, L.L.C. | 1,355,876 | $22.7M | 0.04% | −876,953−39.3% | Reduced |
| VR Adviser, LLC | 1,379,965 | $23.1M | 1.21% | 00.0% | Unchanged |
| Holocene Advisors, LP | 1,533,579 | $25.7M | 0.10% | +217,574+16.5% | Added |
| RTW Investments, LP | 1,705,960 | $28.6M | 0.41% | +653,330+62.1% | Added |
| Alliancebernstein L.P. | 1,854,410 | $31.0M | 0.01% | +125,865+7.3% | Added |
| Citadel Advisors LLC | 1,955,257 | $32.7M | 0.03% | +12,118+0.6% | Added |
| Blue Owl Capital Holdings LP | 2,010,972 | $33.7M | 6.53% | −38,200−1.9% | Reduced |
| Franklin Resources Inc | 2,191,262 | $35.6M | 0.01% | −252,868−10.3% | Reduced |
| Paradigm Biocapital Advisors LP | 2,321,013 | $38.9M | 1.36% | +778,208+50.4% | Added |
| State Street Corp | 2,337,222 | $39.1M | 0.00% | +396,034+20.4% | Added |
| Vanguard Group Inc | 2,998,714 | $50.2M | 0.00% | +127,339+4.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 3,280,000 | $54.9M | 0.82% | −2370.0% | Reduced |
| BlackRock, Inc. | 4,338,725 | $72.6M | 0.00% | +4,338,725 | New |
| BVF Inc | 5,750,683 | $96.3M | 2.82% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 7,648,268 | $128.0M | 19.21% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,125,000−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,057,949−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −749,916−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −190,520−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −163,047−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −150,708−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −136,887−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −98,296−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −34,293−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −34,100−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −25,976−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −12,164−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −11,491−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −2,847−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −595−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |